
Cincinnati Enquirer: Study finds stroke a danger of COVID-19
Local media outlets discuss findings from a UC study linking COVID-19 to stroke, disorientation
In the first major study of COVID-19’s effect on the brain and nervous system, researchers at the University of Cincinnati and in Italy found that of 725 patients in the study, 108 developed serious neurological symptoms including stroke. Nearly a third of the 108 patients had no history of or risk factor for stroke.
These results were published in the journal Radiology.
Read the full Cincinnati Enquirer story.
NPR affiliate WVUX-FM, 91.7, also covered the study.
Featured photo courtesy of Unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
What parvovirus is and why it's on the rise
July 10, 2025
An infectious virus common in children is on the rise in the Tristate. The Cincinnati Health Department is warning of a rise in parvovirus in Hamilton County. The illness can present itself as a rash on the cheeks and is often called “slapped cheek” disease but can present more serious concerns in pregnant women. Kara Markham, MD, professor of obstetrics and gynecology at the University of Cincinnati College of Medicine recently appeared on Cincinnati Edition on WVXU to discuss how parvovirus is transmitted, the risk of serious cases and how to prevent it.
While working 3 a.m. shifts, UC engineer wowed baseball's Big 12
July 10, 2025
UC College of Engineering and Applied Science graduate Kerrington Cross was named an All-American and Big 12 Player of the Year while co-oping in chemical engineering at L'oreal.
UC joins international Phase 1 trial testing CAR-T therapy for MS
July 10, 2025
The University of Cincinnati Gardner Neuroscience Institute is a trial site for a multicenter, international Phase 1 trial testing CAR-T cell therapy for patients with multiple sclerosis.